SCABIES POLICY DOCUMENT CONTROL: Version: Ratified by: Date ratified: Name of originator/author: Name of responsible committee/individual:

Size: px
Start display at page:

Download "SCABIES POLICY DOCUMENT CONTROL: Version: Ratified by: Date ratified: Name of originator/author: Name of responsible committee/individual:"

Transcription

1 SCABIES POLICY DOCUMENT CONTROL: Version: 7 Ratified by: Clinical Quality & Standards Group Date ratified: 4 th August 2015 Name of originator/author: Senior Clinical Nurse Specialist - Infection Prevention and Control Name of responsible committee/individual: Infection Prevention & Control Quality & Standards Committee Date issued: 2 September 2015 Review date: September 2018 Target Audience All Clinical Staff

2 CONTENTS SECTION PAGE NO 1 INTRODUCTION 3 2 PURPOSE Definitions/Explanation of Terms Used 3 3 SCOPE 3 4 RESPONSIBILITIES, ACCOUNTABILITIES AND DUTIES Board of Directors Chief Executive Director of Infection Prevention and Control (DIPC) (Deputy Chief 4 Executive/Director of Nursing) 4.4 Infection Prevention and Control Quality and Standards Committee Infection Control Doctors/Consultant Microbiologists Clinical Nurse Specialists - Infection Prevention & Control Quality & 5 Standards Team 4.7 Consultant Medical Staff/Medical Staff Modern Matrons/Service Managers Chief Pharmacist Staff 6 5 PROCEDURE Scabies information Incubation period Transmission Symptoms Diagnosis Complications of Scabies Treatment of Scabies (see appendix 1 for table Permethrin (Lyclear) First Choice treatment Malathion Aqueous 0.5% Liquid (Derbac M) Ivermectin Management of Additional Treatment Information Additional Information for the Treatment of Children Scabies within a group of patients 9 6 TRAINING IMPLICATIONS 10 7 MONITORING ARRANGEMENTS 10 8 EQUALITY IMPACT ASSESSMENT SCREENING Privacy, Dignity and Respect Mental Capacity Act 11 9 LINKS TO ANY ASSOCIATED DOCUMENTS REFERENCES APPENDICES 12 Appendix 1 List of Scabicides 13 Page 2 of 14

3 1. INTRODUCTION Scabies is a parasitic disease caused by the mite, Scarcopes scabei. Skin to skin contact (direct contact) is the mode of transmission. Hyperkeratotic scabies (also called Norwegian Scabies) is a more infectious variant, which can also be transmitted by fomites. 2. PURPOSE The purpose of this policy is to provide information to staff on the care of patients diagnosed or suspected to have Scabies. The policy content is based on sound infection prevention and control (IPC) principles and national guidance. 2.1 Definitions/Explanation of Terms Used 3. SCOPE Hyperkeratotic adjective - overgrowth and thickening of the outer layer of the skin Fomites - any material, such as bedding or clothing, that may harbour pathogens and therefore convey disease This policy applies to all staff having contact with patients under the care of the Trust, whether in a direct or indirect patient care role regardless of the care environment. Adherence to this policy is the responsibility of all staff employed by the Trust, including agency, locum and bank staff contracted by the Trust. This policy should be read in conjunction with other IPC policies, particularly Hand Hygiene, Standard Infection Prevention and Control Precautions. 4. RESPONSIBILITIES, ACCOUNTABILITIES AND DUTIES All staff working on Trust premises, outreach clinics and community settings including Trust employed staff, contractors, agency and locum staff are responsible for adhering to this policy. 4.1 Board of Directors The Board of Directors are responsible for having policies and procedures in place to support best practice, effective management, service delivery, management of associated risks and meet national and local legislation and/or requirements. 4.2 Chief Executive The Chief Executive is responsible for establishing and maintaining IPC arrangements across the organisation, but delegates the responsibilities to the Trust Board and the Director of Infection Prevention and Control. The Director with the lead responsibility is the Deputy Chief Executive and Lead Nurse. Page 3 of 14

4 4.3 Director of Infection Prevention and Control (DIPC) (Deputy Chief Executive/Director of Nursing) The DIPC acts on legislation, national policies and guidance ensuring effective policies are in place and audited and directly reports to the Chief Executive and the Board of Directors: Any identified cases of infections/alert organisms The organisations performance in relation to Healthcare Associated Infection s (HCAI) and provides regular reports, including an annual report and an annual IPC programme All incidents requiring post infection review (PIR) 4.4 Infection Prevention & Control Quality & Standards Committee (IPCQ&SC) The IPCQ&SC members oversee compliance with international and national standards/targets in relation to the prevention and control of HCAI, including the Health and Social Care Act 2008, NHS Litigation Authority (NHSLA) and the Care Quality Commission (CQC) Fundamental Standards. The main duties of the IPCQ&SC are to oversee key IPC issues in regards to: Policy development and review Audit Education and training compliance Communication with staff, patients and the public Horizon scanning for relevant IPC guidance and documents Monitoring of IPC incidents Ensuring that robust plans for the management of outbreaks of infection are in place and to monitor their effectiveness Reviewing PIR reports in order to identify lessons learnt, develop and monitor action plans Agreeing the annual IPC report and work programme prior to its submission to Clinical Governance Group (CGG) To inform the CGG of clinical risk issues relating to the Trust 4.5 Infection Control Doctors/Consultant Microbiologists Medical microbiologists hosted within the provider acute Trusts are available, through a contractual service level agreement to: Provide expert microbiology advice for the management and treatment of micro-organisms Advise on antibiotic policy/prescribing and challenge inappropriate practices Contribute to the PIR process and attend meetings as required Page 4 of 14

5 4.6 Clinical Nurse Specialists (CNS) Infection Prevention & Control Quality & Standards Team (IPCQ&ST) The IPCQ&ST CNS role is to: Provide expert professional advice and education on the prevention and control of infection to other professionals, multi-disciplinary groups, patients and carers Lead in the investigation of identified cases of infection/alert organisms and conditions Advise on control measures, delegating responsibility to Trust staff as appropriate Give advice on complex issues relating to IPC and report findings to the DIPC Report any breaches in policy compliance through the IR1 system and to the IPCQ&SC 4.7 Consultant Medical Staff/Medical Staff Consultant medical staff are responsible for the supervision of junior medical staff assigned to work with them and all staff must: Ensure compliance with IPC policies Liaise with the Consultant Microbiologist for advice if required Be aware of and comply with antibiotic prescribing guidance Contribute to and participate in relevant meetings as required 4.8 Modern Matrons/Service Managers All Service Managers and Modern Matrons are responsible for: Membership at the IPCQ&SC On-going compliance with this policy within their clinical areas and reporting non-compliance to the DIPC via the IPCQ&SC Reporting all matters relating to IPC to the DIPC Facilitating feedback of information related to surveillance data and identified cases of infection/alert organisms and conditions, including Scabies Reporting confirmed cases of infection/alert organisms and conditions to the IPCQ&ST Reporting any breaches in policy compliance through the IR1 system and to the IPCQ&SC 4.9 Chief Pharmacist The Chief Pharmacist will: Contribute to the PIR process when antibiotics have been prescribed Facilitate and evaluate antibiotic and proton pump inhibitor prescribing Undertake audit as requested by the IPCQ&SC Report findings to Medicines Management Committee and IPCQ&SC Page 5 of 14

6 4.10 Staff All staff must comply with this policy and related guidance. 5. PROCEDURE/IMPLEMENTATION 5.1 Scabies Information There are two types of scabies. These being Classical Scabies, which is found in people with normal immune systems and Hyperkeratotic Scabies (also known as Norwegian Scabies), which is often found in the elderly population or those with suppressed immune systems. In Norwegian Scabies the skin becomes thickened, scaled and crusted due to the large number of mites present and is highly contagious due to the number of mites present in the exfoliating skin scales. The scabies mite is extremely small, with the female measuring 0.4 mm in length and the male 0.2 mm. A scabies infestation starts when a mite burrows under the top layer of the skin. They may occur anywhere on the body and the burrows are usually about 5 mm long. 5.2 Incubation period The incubation period is up to 8 weeks. This extended length of incubation time can make the identification and control of scabies difficult, especially in residential social care settings. 5.3 Transmission Scabies mites are not able to jump or fly. The usual method of transmission is through direct and prolonged periods of contact (10-20 minutes) or intimate skin contact. It's unlikely that scabies will be transmitted through brief physical contact, such as shaking hands or hugging. Classical scabies mites can survive outside the human body for 24 to 36 hours, making infestation by coming into contact with contaminated clothes, towels or bed linen a rare possibility, unless they have been contaminated by the infested individual immediately beforehand. In addition to transmission by direct contact, Hyperkeratotic Scabies is easily transmissible via clothing, towels or bedding due to the large number of mites present in the exfoliating skin scales. Hyperkeratotic Scabies mites can survive outside the human body for up to 7 days as they are able to feed on skin scales in bedding, towels or clothing. 5.4 Symptoms The main symptoms of scabies infection are caused through an allergic response to the presence of the mite. This is thought to be caused by the immune system reacting to the mites and their saliva, eggs and faeces. Severe itching develops, especially at night. It may take four to six weeks Page 6 of 14

7 5.5 Diagnosis before the itching starts, however, if the person has had a previous scabies infection, the immune response is rapid and itching develops in hours to days. A rash may develop consisting of tiny red spots and scratching the rash may cause crusty sores to develop. Scabies is usually diagnosed through the presence of intense itching with a follicular papular rash and the burrow marks of the mite. However, as scabies is spread very easily, it's often possible to make a confident diagnosis if more than one family member has the same symptoms 5.6 Complications of Scabies Repeatedly scratching itchy skin may break the skin's surface which may lead to the development of a secondary skin infection. In this situation clinical review and antibiotic therapy may be required. Scabies has been known to make some pre-existing skin conditions, such as eczema, worse. However, other skin conditions should settle down after the scabies infection has been successfully treated. 5.7 Treatment of Scabies (see appendix 1 for table) Permethrin (Lyclear) First Choice treatment. Permethrin Cream (Lyclear 5%) is currently the agent of choice for the treatment of scabies and also for prophylactic treatment for contacts and can be used in pregnancy Permethrin is licensed for use in children over 2 months of age. It is recommended that medical supervision should be sought before applying to children s skin under 2 years of age. Permethrin is a cream, which should be applied and left for 8-12 hours The treatment requires 2 applications 1 week apart In Hyperkeratotic Scabies more than 2 applications on consecutive days may be required. Advice must be obtained from medical staff/dermatology specialists Avoid contact with eyes due to irritation One tube of Permethrin is usually adequate for an average sized person however in obese patients more tubes will be required This is a vanishing cream and so disappears on application. It should be continuously applied until it remains detectable on the skin surface Page 7 of 14

8 5.7.2 Malathion Aqueous 0.5% Liquid (Derbac M) This medication is a lotion and should be left on the body for 24 hours It should not be used more often than once a week for a maximum of three consecutive weeks Avoid in children less than 6 months of age, seek medical advice Can be used in pregnancy Aqueous preparations are preferable to alcoholic lotions, as they are less of an irritant to the skin and respiratory tract Ivermectin This is an oral medication that is only given on a named patient basis within the UK. The decision to prescribe should only be undertaken after consultation with the Dermatology Department. Topical treatments may also be applied in conjunction with the oral medication being given particularly in Hyperkeratotic Scabies that does not respond to oral topical treatment alone Management and Additional Treatment Information As the incubation period can be up to 8 weeks it is important to consider any person who has had prolonged skin to skin contact within the last 8 weeks, as requiring treatment. Ensure the skin is clean, dry and cool before application. A hot bath should be avoided as evidence suggests this could reduce its efficacy. All members of the affected household should be treated at the same time, as prescribed by their GP, to ensure that individuals do not re-infect one another. Apply the cream or lotion to the scalp, jaw line and all over the body including the genital area. Pay particular attention to the webbed areas of toes and fingers. Occasionally an application to the head may be recommended. Applying the cream at night before going to bed is usually the best time because it can be left on overnight. Healthcare staff applying the cream or lotion should wear disposable gloves and a disposable apron with each individual they are treating. In the case of treatment application/care of patients with Hyperkeratotic Scabies arm protection would be advisable. A second person is necessary when treating oneself, to ensure all the body is covered. Nails should be trimmed and medication applied with cotton wool buds Page 8 of 14

9 underneath the nails and around the nail bed area. If hands are subsequently washed, then further treatment needs to be applied. If any part of the body requires washing/cleaning during the treatment time schedule the cream/lotion will need to be reapplied after each wash e.g. after changing continence products. The treatment should be left on for the manufacturers recommended time period. Remove the treatment by thorough washing of all areas of the skin to which it has been applied. Once the treatment has been applied and washed off, wash all bedding and clothing immediately on a hot wash cycle. In healthcare settings, bedding and clothing should be treated as infected linen and red alginate bags should be used (refer to the Laundry Policy). Itching and rash may persist or even become slightly worse for a few days following treatment due to the continuing presence of dead mites and the dead mites faeces in the skin. Antihistamine medication may be useful in this situation. Exclude from school/workplace until 24 hours after treatment has been started. Prolonged skin to skin contact should be avoided wherever possible until 24 hours after treatment. Notify Public Health England on when there is an outbreak of scabies. An outbreak of infection is defined as the occurrence of two or more related cases of the same infection, or where the number of infections is more than would normally be expected (Wilson, 2001). Seek additional advice from the IPC team if required. A Consultant Dermatologist or Consultant Microbiologist can advise on the choice of agent for treatment Additional Information for the Treatment of Children Children under the age of two may also have mites on the face, neck, scalp, ears and the soles of their feet. It is therefore important to pay particular attention to the head, neck, flexor areas and the soles of the feet. Special care must be taken in the selection of the scabicide. 5.8 Scabies Within A Group Of Patients If there is a single case of scabies within a healthcare setting the patient does not require isolation (except with Hyperkeratotic Scabies due to exfoliating skin scales) and can be left in the usual area whilst being treated. Staff Page 9 of 14

10 should however be extremely vigilant for signs and symptoms of scabies in other patients or clients during the following weeks. If there appears to be more than one case of scabies, diagnosis must be confirmed by a Dermatologist before commencing treatment of patients. Treatment will be carried out in consultation with the IPCQ&ST. The Occupational Health Department should be informed of the situation though staff are to contact their own General Practitioner for advice/treatment. 6. TRAINING IMPLICATIONS There are no specific training needs in relation to this policy, but the following staff will need to be familiar with its contents: All clinical staff having face to face contact with patients and any other individual or group with a responsibility for implementing the contents of this policy. As a Trust policy, all staff need to be aware of the key points that the policy covers. Staff can be made aware through: A number of a variety of means such as; Team Brief Trust wide mail drop Team meetings One to one meetings / Supervision Posters CPD sessions Weekly Newsletter Trust wide Special meetings Group supervision Practice Development Days Local Induction 7. MONITORING ARRANGEMENTS Area for Monitoring How Who by Reported to Frequency Noncompliance to policy Monitor breaches in policy via IR1 reporting system. IPCQ&S CNS IPCQ&SC Bi-monthly 8. EQUALITY IMPACT ASSESSMENT SCREENING The completed Equality Impact Assessment for this Policy has been published on the Equality and Diversity webpage of the RDaSH website click here Page 10 of 14

11 8.1 Privacy, Dignity and Respect The NHS Constitution states that all patients should feel that their privacy and dignity are respected while they are in hospital. High Quality Care for All (2008), Lord Darzi s review of the NHS, identifies the need to organise care around the individual, not just clinically but in terms of dignity and respect. Indicate how this will be met No issues have been identified in relation to this policy. As a consequence the Trust is required to articulate its intent to deliver care with privacy and dignity that treats all service users with respect. Therefore, all procedural documents will be considered, if relevant, to reflect the requirement to treat everyone with privacy, dignity and respect, (when appropriate this should also include how same sex accommodation is provided). 8.2 Mental Capacity Act Central to any aspect of care delivered to adults and young people aged 16 years or over will be the consideration of the individuals capacity to participate in the decision making process. Consequently, no intervention should be carried out without either the individuals informed consent, or the powers included in a legal framework, or by order of the Court Therefore, the Trust is required to make sure that all staff working with individuals who use our service are familiar with the provisions within the Mental Capacity Act. For this reason all procedural documents will be considered, if relevant to reflect the provisions of the Mental Capacity Act 2005 to ensure that the interests of an individual whose capacity is in question can continue to make as many decisions for themselves as possible. Indicate How This Will Be Achieved. All individuals involved in the implementation of this policy should do so in accordance with the Guiding Principles of the Mental Capacity Act (Section 1) 9. LINKS TO ANY ASSOCIATED DOCUMENTS This policy should be read in conjunction with other Trust IPC and relevant clinical policies. All policies can be found in the Clinical Policies section of the intranet 10. REFERENCES British National Formulary and British National Formulary for children. April accessed Chin J. (2002). Control of Communicable Diseases Manual American Public Health Association. Page 11 of 14

12 accessed National Institute for Health and Clinical Excellence (2012) Prevention and control of healthcare associated infections in primary and community care. NICE clinical guideline 139 Prodigy. Quick reference guide issued June Sheffield District Infection Control Team (2003). Sheffield District Control of Infection Guidelines. Unpublished Wilson J. (2006). Infection Control in Clinical Practice. 3 rd ed. Baillere Tindall. London. accessed Accessed APPENDICES Appendix 1 List of Scabicides Page 12 of 14

13 LIST OF SCABICIDES: Appendix 1 First Choice Treatment: Permethrin (Lyclear Dermal Cream) Two applications of treatment are used 7 days apart Drug Age Dose Quantity Notes, Permethrin 5% dermal cream 2 months to 2 year Apply to the whole body, including the scalp, face, neck and ears. Leave on for 8-12 hours or overnight. Wash off. 2 to 11 years Apply to the whole body, including the scalp, face, neck and ears. Leave on for 8-12 hours or overnight. Wash off. Repeat after 7 days. 30g** 30g* Cautions/Contraindications Avoid contact with eyes Do not use on broken or secondarily infected skin Do not use in pregnancy or whilst breast feeding For children under 2 years medical supervision is required 12 years onwards Apply to the whole body, including the scalp, face, neck and ears. Leave on for 8-12 hours or overnight. Wash off. Repeat after 7 days. 60g* (may be required) *Two 30g tubes may be required for each application for an adult. For children up to the age of 2 years, one eighth to one quarter of a tube should be enough for each application. Children between 2 and 6 years need about a quarter of a tube per application, and children between 6 and 12 years need about half a tube per application. **A single application is usually sufficient for children under 2 years of age. Page 13 of 14

14 Second Choice Treatment: Malathion (Derbac M) Two applications of treatment are used 7 days apart Drug Age Dose Quantity Notes, Cautions/Contraindications 6 months to 1 Apply to the whole body, including the scalp, face, 100ml* year neck and ears. Malathion 0.5% aqueous liquid 2 years onwards Pregnancy and Breast Feeding: Malathion (Derbac M) Malathion 0.5% aqueous liquid Leave on for 24 hours. Wash off Apply to the whole body, including the scalp, face, neck and ears. Leave on for 24 hours. Wash off. Repeat after 7 days (unlicensed use see notes in BNF) 200ml* Avoid contact with eyes Do not use on broken or secondarily infected skin Do not use more than once a week for three weeks at a time For children under six months, medical supervision is required Drug Age Dose Quantity Notes, Cautions/Contraindications 12 years Apply to the whole body, including the scalp, face, 100ml onwards neck and ears. Leave on for 24 hours. Wash off If the person requiring treatment has broken skin areas e.g. ulcers, pressure sores, contact a Dermatologist for advice. Avoid contact with eyes Do not use on broken or secondarily infected skin Do not use more than once a week for three weeks at a time Ivermectin (available on a named patient basis from special-order manufacturers or specialist importing companies) in a dose of 200 micrograms/kg by mouth has been used, in combination with topical drugs, for the treatment of Hyperkeratotic Scabies that does not respond to topical treatment alone; further doses of 200 micrograms/kg may be required. Page 14 of 14

STANDARD OPERATING PROCEDURE (SOP) SCABIES POLICY TRANSMISSION BASED PRECAUTIONS.

STANDARD OPERATING PROCEDURE (SOP) SCABIES POLICY TRANSMISSION BASED PRECAUTIONS. Page Page 1 of 10 SOP Objective To provide Heath Care Workers (HCWs) with details of the care required to prevent crossinfectionin patients with Scabies.. This SOP applies to all staff employed by NHS

More information

SCABIES PROTOCOL IN WRHA COMMUNITY HEALTH SERVICES CLIENTS AND STAFF

SCABIES PROTOCOL IN WRHA COMMUNITY HEALTH SERVICES CLIENTS AND STAFF SCABIES PROTOCOL IN WRHA COMMUNITY HEALTH SERVICES CLIENTS AND STAFF Preamble: This algorithm and guideline were developed to assist Community Health Services personnel in managing scabies in the community.

More information

POLICY FOR THE MANAGEMENT OF CHICKENPOX/SHINGLES

POLICY FOR THE MANAGEMENT OF CHICKENPOX/SHINGLES POLICY FOR THE MANAGEMENT OF CHICKENPOX/SHINGLES DOCUMENT CONTROL: Version: 4 Ratified by: Clinical Effectiveness Committee Date ratified: 9 August 2012 Name of originator/author: Infection Prevention

More information

N/A. Director of Nursing and Operations, DIPC. Infection Prevention and Control. IPC Meeting Members

N/A. Director of Nursing and Operations, DIPC. Infection Prevention and Control. IPC Meeting Members Document Details Title Trust Ref No 782-30737 Local Ref (optional) Main points the document covers Who is the document aimed at? Author Approval process Approved by (Committee/Director) Approval Date 26

More information

Aseptic Non-Touch Technique Policy

Aseptic Non-Touch Technique Policy Aseptic Non-Touch Technique Policy DOCUMENT CONTROL: Version: 4 Ratified by: Quality and Safety Sub Committee Date ratified: 4 July 2016 Name of originator/author: Karen Foltyn, Senior Clinical Nurse Specialist,

More information

Management of Scabies in Health and Social Care Settings

Management of Scabies in Health and Social Care Settings Management of Scabies in Health and Social Care Settings This information applies to long term care facilities, residential homes and day care centres. Many outbreaks of scabies in long-stay facilities

More information

CARING FOR PATIENTS WITH SUSPECTED OR CONFIRMED PULMONARY TUBERCULOSIS POLICY

CARING FOR PATIENTS WITH SUSPECTED OR CONFIRMED PULMONARY TUBERCULOSIS POLICY CARING FOR PATIENTS WITH SUSPECTED OR CONFIRMED PULMONARY TUBERCULOSIS POLICY DOCUMENT CONTROL: Version: 5 Ratified by: Clinical Quality and Standards Group Date ratified: 5 May 2015 Name of originator/author:

More information

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

South Staffordshire and Shropshire Healthcare NHS Foundation Trust South Staffordshire and Shropshire Healthcare NHS Foundation Trust 1 Document Version Control Document Type and Title: Authorised Document Folder: Policy for the Management of Parasitic Infestations YELLOW

More information

The Management of Patients with Scabies policy. Infection Prevention and Control

The Management of Patients with Scabies policy. Infection Prevention and Control The Management of Patients with Scabies policy Infection Prevention and Control Description: This policy describes the processes and procedures for the management of patients with known or suspected scabies

More information

POLICY FOR THE MANAGEMENT OF BLOOD AND BODY FLUID SPILLAGES

POLICY FOR THE MANAGEMENT OF BLOOD AND BODY FLUID SPILLAGES POLICY FOR THE MANAGEMENT OF BLOOD AND BODY FLUID SPILLAGES DOCUMENT CONTROL: Version: V61 Ratified by: Clinical Quality and Standards Group Date ratified: 5 May 2015 Name of originator/author: Senior

More information

Checklists for Preventing and Controlling

Checklists for Preventing and Controlling Checklists for Preventing and Controlling Clostridium difficile Infection (CDI) This document has been developed to specifically assist senior management and all ward staff to take appropriate actions,

More information

Protocol for the Self Administration of Medication within the Locked Rehabilitation and Recovery Inpatient Unit

Protocol for the Self Administration of Medication within the Locked Rehabilitation and Recovery Inpatient Unit Protocol for the Self Administration of Medication within the Locked Rehabilitation and Recovery Inpatient Unit DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Assurance Sub Group Date ratified: 28

More information

Developed in response to: Best Practice Infection Prevention and Control

Developed in response to: Best Practice Infection Prevention and Control Transfer of patients within MEHT Clinical Guideline Developed in response to: Best Practice Infection Prevention and Control Version Number 1.0 Issuing Directorate Corporate Governance Approved by Clinical

More information

PATIENT GROUP DIRECTION

PATIENT GROUP DIRECTION PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% FOR THE TREATMENT OF IMPETIGO BY COMMUNITY PHARMACISTS UNDER THE PHARMACY FIRST SERVICE IN NHS HIGHLAND THE COMMUNITY PHARMACIST SEEKING

More information

Suspected case: Person has clinical features of scabies infestation (See #2 below).

Suspected case: Person has clinical features of scabies infestation (See #2 below). POLICIES & PROCEDURES Number: 55-50 Title: Scabies Outbreak Authorization: X SHR Regional Infection Prevention & Control Committee Source: Infection Prevention & Control Date Initiated: November 2006 Date

More information

Hoist and Sling for Safer Patient Use Policy

Hoist and Sling for Safer Patient Use Policy Hoist and Sling for Safer Patient Use Policy DOCUMENT CONTROL: Version: 4 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Back Care Advisor Name

More information

Guidelines for In-patient and Residential staff. Staff in Mental Health and Learning Disability In-

Guidelines for In-patient and Residential staff. Staff in Mental Health and Learning Disability In- Guidelines for In-patient and Residential staff in Mental Health and Learning Disability Services for contacting the On call -Training Grade Doctor/GP DOCUMENT CONTROL Version 4.2 Ratified by Quality and

More information

Infection Prevention and Control (IPC) Standard Operating Procedure for LICE (PEDICULOSIS AND PHTHIRIASIS) in a healthcare setting

Infection Prevention and Control (IPC) Standard Operating Procedure for LICE (PEDICULOSIS AND PHTHIRIASIS) in a healthcare setting Infection Prevention and Control (IPC) Standard Operating Procedure for LICE (PEDICULOSIS AND PHTHIRIASIS) in a healthcare setting WARNING This document is uncontrolled when printed. Check local intranet

More information

HANDLING OF LAUNDRY POLICY

HANDLING OF LAUNDRY POLICY HANDLING OF LAUNDRY POLICY Version: 6 Ratified by: Date ratified: November 2015 Title of originator/author: Title of responsible committee/group: Senior Managers Operational Group Facilities Manager Estates

More information

NHS GREATER GLASGOW & CLYDE CONTROL OF INFECTION COMMITTEE STANDARD OPERATING PROCEDURE (SOP) GROUP A STREPTOCOCCUS (Streptococcus pyogenes)

NHS GREATER GLASGOW & CLYDE CONTROL OF INFECTION COMMITTEE STANDARD OPERATING PROCEDURE (SOP) GROUP A STREPTOCOCCUS (Streptococcus pyogenes) Page Page 1 of 9 SOP Objective To ensure Healthcare Workers (HCWs) are aware of the actions and precautions necessary to minimise the risk of cross-infection and the importance of diagnosing patients clinical

More information

Infection Control Safety Guidance Document

Infection Control Safety Guidance Document Infection Control Safety Guidance Document Lead Directorate and Service: Corporate Resources - Human Resources, Safety Services Effective Date: June 2014 Contact Officer/Number Garry Smith / 01482 391110

More information

RESEARCH GOVERNANCE POLICY

RESEARCH GOVERNANCE POLICY RESEARCH GOVERNANCE POLICY DOCUMENT CONTROL: Version: V6 Ratified by: Performance and Assurance Group Date ratified: 12 November 2015 Name of originator/author: Assistant Director of Research Name of responsible

More information

INFECTION CONTROL SURVEILLANCE POLICY

INFECTION CONTROL SURVEILLANCE POLICY INFECTION CONTROL SURVEILLANCE POLICY Version: 3 Ratified by: Date ratified: July 2016 Title of originator/author: Title of responsible committee/group: Senior Managers Operational Group Head of Infection

More information

Tuberculosis (TB) Procedure

Tuberculosis (TB) Procedure Tuberculosis (TB) Procedure (IPC Manual) DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Policies Review and Approval Group Date ratified: 4 September 2018 Name of originator/author: RDaSH Community

More information

Clinical Audit Policy

Clinical Audit Policy Clinical Audit Policy DOCUMENT CONTROL Version: 5 Ratified by: Quality Assurance Group Date ratified: 3 July 2017 Name of originator/author: Clinical Quality Lead Senior Clinical Audit Facilitator Name

More information

Section 132 of the Mental Health Act 1983 Procedure for Informing Detained Patients of their Legal Rights

Section 132 of the Mental Health Act 1983 Procedure for Informing Detained Patients of their Legal Rights Section 132 of the Mental Health Act 1983 Procedure for Informing Detained Patients of their Legal Rights DOCUMENT CONTROL: Version: 11 Ratified by: Mental Health Legislation Sub Committee Date ratified:

More information

Laundry Policy. DOCUMENT CONTROL: Version: 8 Quality Assurance Sub Committee Date ratified: 30 October 2017 Name of

Laundry Policy. DOCUMENT CONTROL: Version: 8 Quality Assurance Sub Committee Date ratified: 30 October 2017 Name of Laundry Policy DOCUMENT CONTROL: Version: 8 Ratified by: Quality Assurance Sub Committee Date ratified: 30 October 2017 Name of Head of Facilities originator/author: Name of responsible Estates Sub Committee

More information

Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.

Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. This document authorises the supply of Fusidic Acid Cream 2% by registered

More information

PROCEDURE FOR TAKING A WOUND SWAB

PROCEDURE FOR TAKING A WOUND SWAB CLINICAL PROCEDURE PROCEDURE FOR TAKING A WOUND SWAB Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date 2 To provide a standardised process of the fundamental principles

More information

SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS (VRE)

SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS (VRE) SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS () Introduction Definitions Associated with Risk Groups Signs and Symptoms Source Mode of Transmission Diagnosis Treatment Screening Transport Communication

More information

SCABIES SURVEILLANCE PROTOCOL FOR ONTARIO HOSPITALS

SCABIES SURVEILLANCE PROTOCOL FOR ONTARIO HOSPITALS SCABIES SURVEILLANCE PROTOCOL FOR ONTARIO HOSPITALS Developed by the Ontario Hospital Association and the Ontario Medical Association Joint Communicable Diseases Surveillance Protocols Committee Approved

More information

Patient Group Direction For the supply of Fusidic Acid 2% Cream

Patient Group Direction For the supply of Fusidic Acid 2% Cream Patient Group Direction For the supply of Fusidic Acid 2% Cream This Patient Group Direction (PGD) is a specific written instruction for the supply of Fusidic Acid 2% Cream to groups of patients who may

More information

The most up to date version of this policy can be viewed at the following website:

The most up to date version of this policy can be viewed at the following website: Page Page 1 of 6 Policy Objective To ensure that HCWs are aware of the actions and precautions necessary to minimise the risk of cross-infection and the importance of diagnosing patients clinical conditions

More information

Standard Precautions for Infection Control

Standard Precautions for Infection Control Standard Precautions for Infection Control Author(s) & Designation Lead Clinician if appropriate In consultation with To be read in association with Ratified by Suzanne Golding-Ellis, Head of Patient Safety

More information

Clostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions

Clostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions Page 1 of 9 Standard Operating procedure (SOP) Objective To provide HCWs with details of the care required to prevent cross-infection in children s with Clostridium difficile Infection (CDI). This SOP

More information

NHS Lothian Patient Group Direction Version: 001

NHS Lothian Patient Group Direction Version: 001 PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% TO TREAT MINOR STAPHYLOCOCCAL SKIN INFECTIONS (IMPETIGO) IN PATIENTS AGED OVER 2 YEARS BY PHARMACISTS WORKING WITHIN NHS LOTHIAN COMMUNITY

More information

METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change

METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE First Issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date 10/2008 1 Guidance

More information

Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2

Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2 Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2 Date protocol prepared: October 2017 Date protocol due for review: October 2019 Expiry date: October

More information

BEREWOOD PRIMARY SCHOOL

BEREWOOD PRIMARY SCHOOL BEREWOOD PRIMARY SCHOOL Intimate Care Policy February 2015 Revised by School June 2014 Responsible Person Sue Patrick (head teacher) Responsible Committee Full Governing Body Ratified by GB February 2015

More information

Protocol for the Prevention and Management of Clostridium difficile.

Protocol for the Prevention and Management of Clostridium difficile. Protocol for the Prevention and Management of Clostridium difficile. Policy Profile Policy Reference: Clinical care protocol 14. App D Clin 2.0 Version: Version 2.1 Author: Selma Mehdi, Lead Nurse Infection

More information

Infection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases

Infection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases Infection Prevention Infection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases to yourself, family members,

More information

ASEPTIC & CLEAN (NON TOUCH TECHNIQUE) POLICY

ASEPTIC & CLEAN (NON TOUCH TECHNIQUE) POLICY ASEPTIC & CLEAN (NON TOUCH TECHNIQUE) POLICY First Issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date 4 Update September 2012 Named Responsible Officer:- Approved by

More information

POLICY FOR THE MANAGEMENT OF PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION

POLICY FOR THE MANAGEMENT OF PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION POLICY FOR THE MANAGEMENT OF PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION DOCUMENT CONTROL: Version: 3 Ratified by: Clinical Effectiveness Committee Date ratified: 9 August 2012 Name of originator/author:

More information

Isolation Care of Patients in Isolation due to Infection or Disease

Isolation Care of Patients in Isolation due to Infection or Disease Infection Prevention and Control Assurance - Standard Operating Procedure 6 (IPC SOP 6) Isolation Care of Patients in Isolation due to Infection or Disease Why we have a procedure? The spread of infection

More information

Hand Hygiene Policy. Documentation Control

Hand Hygiene Policy. Documentation Control Documentation Control Reference CL/CGP/039 Approving Body Trust Board Date Approved 3 Implementation date 3 Supersedes NUH Version 2 (May 2009) Consultation undertaken Infection Prevention and Control

More information

Intimate and Personal Care of Children Policy

Intimate and Personal Care of Children Policy Coston Primary School Intimate and Personal Care of Children Policy Committee with oversight for this policy Full Governing Body Policy to be signed off by the Full Governing Body Policy last reviewed

More information

Requesting a Second Opinion Policy

Requesting a Second Opinion Policy Requesting a Second Opinion Policy DOCUMENT CONTROL: Version: 2 Ratified by: Quality and Safety Sub Committee Date ratified: 31 July 201 Name of originator/author: Doncaster Locality Manager, Adult Mental

More information

Preventing Infection in Care

Preventing Infection in Care Infection Prevention and Control: Older Person Care Homes & Home Environment Learning Programme Workbook NHS Education for Scotland 2011. You can copy or reproduce the information in this document for

More information

Everyone Involved in providing healthcare should adhere to the principals of infection control.

Everyone Involved in providing healthcare should adhere to the principals of infection control. Infection Control Introduction The prevention and control of infection is an integral part of the role of all health care personnel. Healthcare Associated Infections (HCAIs) affect an estimated one in

More information

SOUTH DARLEY C of E PRIMARY SCHOOL INTIMATE AND PERSONAL CARE POLICY

SOUTH DARLEY C of E PRIMARY SCHOOL INTIMATE AND PERSONAL CARE POLICY SOUTH DARLEY C of E PRIMARY SCHOOL INTIMATE AND PERSONAL CARE POLICY Person/Committee responsible for reviewing/updating this plan Premises, Health & Safety Date of Review Governors Meeting Reference Number

More information

: Hand. Hygiene Policy NAME. Author: Policy and procedure. Version: V 1.0. Date created: 11/15. Date for revision: 11/18

: Hand. Hygiene Policy NAME. Author: Policy and procedure. Version: V 1.0. Date created: 11/15. Date for revision: 11/18 : Hand NAME Hygiene Policy Target Audience Author: Type: Clinical staff BD Policy and procedure Version: V 1.0 Date created: 11/15 Date for revision: 11/18 Location: Dropbox/website Hand Hygiene Policy

More information

OPERATIONAL POLICY INFECTION PREVENTION AND CONTROL POLICY NO.1

OPERATIONAL POLICY INFECTION PREVENTION AND CONTROL POLICY NO.1 OPERATIONAL POLICY INFECTION PREVENTION AND CONTROL POLICY NO.1 Applies to: All employees of Wirral Community NHS Trust Group for Approval Infection Prevention and Control Group Date of Approval 25 January

More information

Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE)

Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE) Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE) Author: Responsible Lead Executive Director: Endorsing Body: Governance or Assurance

More information

abc INFECTION CONTROL STRATEGY

abc INFECTION CONTROL STRATEGY abc INFECTION CONTROL STRATEGY 1. INTRODUCTION East and North Hertfordshire NHS Trust (ENHT) considers the reduction of Healthcare Associated infections (HCAI) a key component of patient safety systems

More information

Medication Policy. Linked to National Quality Standards- Quality Area Two: Element Policy statement

Medication Policy. Linked to National Quality Standards- Quality Area Two: Element Policy statement Medication Policy Administering medication should be considered a high risk practice. Authority must be obtained from a parent or legal guardian before educators administer any medication (prescribed or

More information

West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13

West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13 Introduction purpose: West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan 2012-2013 [Updated 19/3/13] Item 37/13 This action plan has been developed by West Hertfordshire

More information

5.5. The Strawberry Patch Nursery and Pre-school. Illness Policy

5.5. The Strawberry Patch Nursery and Pre-school. Illness Policy Policy statement 5.5 The Strawberry Patch Nursery and Pre-school Illness Policy At The Strawberry Patch we recognise it is our responsibility to ensure the Health and Safety for our children, staff and

More information

HEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE

HEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE HEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE Author: Jenny Boyce, Lead Infection Prevention & Control Nurse Approved by and date: March 2016 Any other linked ICP 000 - Infection Prevention

More information

Linen Services Policy

Linen Services Policy Policy No: IC10 Version: 6.0 Name of Policy: Linen Services Policy Effective From: 18/08/2015 Date Ratified 15/07/2015 Ratified Infection Prevention and Control Committee Review Date 01/07/2017 Sponsor

More information

DEFINITION Pinworms are a parasitic infestation of the cecum of the large bowel. It is more common in children.

DEFINITION Pinworms are a parasitic infestation of the cecum of the large bowel. It is more common in children. DEFINITION Pinworms are a parasitic infestation of the cecum of the large bowel. It is more common in children. IMMEDIATE CONSULTATION REQUIRED IN THE FOLLOWING SITUATIONS None CAUSES Enterobius vermicularis

More information

TRUST POLICY AND PROCEDURE FOR THE MANAGEMENT AND CONTROL OF DIARRHOEA AND VOMITING (NOROVIRUS) INFECTIONS

TRUST POLICY AND PROCEDURE FOR THE MANAGEMENT AND CONTROL OF DIARRHOEA AND VOMITING (NOROVIRUS) INFECTIONS TRUST POLICY AND PROCEDURE FOR THE MANAGEMENT AND CONTROL OF DIARRHOEA AND VOMITING (NOROVIRUS) INFECTIONS Reference Number POL-IC/1079/2011 Old ref no. CL-RM/2014/066 Version 1.2.0 Status Final Author:

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Animals on Hospital Premises Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Animals on Hospital Premises Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Animals on Hospital Premises Policy Version No. 6.0 Effective From: 16 March 2018 Expiry Date: 16 March 2021 Date Ratified: 06 March 2018 Ratified

More information

Infection Prevention, Control & Immunizations

Infection Prevention, Control & Immunizations Infection Control: This facility task must be used to investigate compliance at F880, F881, and F883. For the purpose of this task, staff includes employees, consultants, contractors, volunteers, and others

More information

Preventing Further Spread of CPE

Preventing Further Spread of CPE Provisional Guidance relating to CPE for General Practice. May 26 2017. Issued by the HSE Health Care Associated Infection and Antimicrobial Resistance Response Team. What is CPE (Carbapenemase Producing

More information

Policy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection.

Policy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection. Page Page 1 of 6 Policy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection. 1 Responsibilities 2 General information on RSV 3

More information

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 22 FEBRUARY 2012

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 22 FEBRUARY 2012 SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS C 22 FEBRUARY 2012 Subject: Supporting : Author: Status (see footnote): Update on the Clostridium difficile (C.diff)

More information

Infection Control and Prevention On-site Review Tool Hospitals

Infection Control and Prevention On-site Review Tool Hospitals Infection Control and Prevention On-site Review Tool Hospitals Section 1.C. Systems to Prevent Transmission of MDROs Ask these questions of the IP. 1.C.2 Systems are in place to designate patients known

More information

Infection Prevention Control Team

Infection Prevention Control Team Title Document Type Document Number Version Number Approved by Infection Control Manual Section 3.1 Isolation Precautions and Infection Control Care Plan Policy 3 rd Edition Infection Control Committee

More information

Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 1

Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 1 Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 Date protocol prepared: December 2015 Date protocol due for review: December 2017 This patient group direction

More information

POLICY FOR TAKING BLOOD CULTURES

POLICY FOR TAKING BLOOD CULTURES Sponsor: Reviewer(s): Dr Roberta Parnaby (Consultant Microbiologist) Dr Alicja Baczynska (F2 Microbiology) Dr Chris Gordon (Medical Director) Dr Roberta Parnaby Dr Matthew Dryden (Consultant Microbiologists)

More information

The Newcastle upon Tyne NHS Hospitals Foundation Trust. Latex Operational Policy

The Newcastle upon Tyne NHS Hospitals Foundation Trust. Latex Operational Policy The Newcastle upon Tyne NHS Hospitals Foundation Trust Version No.: 4.2 Effective From: 27 October 2015 Expiry Date: 27 October 2018 Date Ratified: 1 July 2015 Ratified By: Clinical Risk Group 1 Introduction

More information

Decontamination of Medical and Laboratory Equipment Prior to Maintenance or Transportation

Decontamination of Medical and Laboratory Equipment Prior to Maintenance or Transportation Decontamination of Medical and Laboratory Equipment Prior to Maintenance or Transportation Version 4.0 Date to be reviewed January 2020 To be reviewed by Medical Engineering Manager Policy Title: Decontamination

More information

PATIENT IDENTIFICATION POLICY

PATIENT IDENTIFICATION POLICY PATIENT IDENTIFICATION POLICY DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Effectiveness Committee Date ratified: 12 th January 2012 Name of originator/author: Clinical Policy Advisor Name of responsible

More information

APPROVED CLINICIAN (AC) POLICY FOR MEDICAL STAFF

APPROVED CLINICIAN (AC) POLICY FOR MEDICAL STAFF APPROVED CLINICIAN (AC) POLICY FOR MEDICAL STAFF Version: 1 Ratified by: Date ratified: August 2015 Title of originator/author: Title of responsible committee/group: Date issued: August 2015 Review date:

More information

Best Practice Guidelines BPG 5 Catheter Care

Best Practice Guidelines BPG 5 Catheter Care Best Practice Guidelines BPG 5 Catheter Care BGP 5 1 DOCUMENT STATUS: Reviewed DATE ISSUED: March 2014 DATE TO BE REVIEWED: 13.10.17 AMENDMENT HISTORY VERSION DATE AMENDMENT HISTORY V1 March 2014 New Guideline

More information

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Prevention and Control of Infection in Care Homes Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Content for today Importance of IPAC -refresher IPAC audits in

More information

Safeguarding Children Policy

Safeguarding Children Policy Safeguarding Children Policy DOCUMENT CONTROL Version: 12.1 Ratified by Quality and Safety Sub Committee Date ratified: 4 September 2017 Name of originator/author: Associate Nurse Director Children s Care

More information

Infection Prevention and Control in Ambulatory Care Settings: Minimum Expectations for Safe Care

Infection Prevention and Control in Ambulatory Care Settings: Minimum Expectations for Safe Care Infection Prevention and Control in Ambulatory Care Settings: Minimum Expectations for Safe Care Melissa Schaefer, MD Division of Healthcare Quality Promotion Centers for Disease Control and Prevention

More information

Infection Control Policy

Infection Control Policy Infection Control Policy Category Summary Policy This policy outlines BAPAM s principles and procedures for infection prevention and control in the clinics environment. It is applicable to all BAPAM personnel

More information

Standard Precautions

Standard Precautions Standard Precautions Speciality: Infection Control 1. Indications 1.1 Background Standard Precautions This definition broadens the coverage of the previously known Universal Precautions by recognizing

More information

MRSA. Information for patients Infection Prevention and Control. Large Print

MRSA. Information for patients Infection Prevention and Control. Large Print MRSA Information for patients Infection Prevention and Control Large Print page 2 of 16 What is MRSA? MRSA is a bacterium (germ), which can be found living on the skin of healthy individuals, particularly

More information

Pulmonary Tuberculosis Policy

Pulmonary Tuberculosis Policy Pulmonary Tuberculosis Policy Author: Owner: Publisher: Linda Horton-Fawkes Infection Prevention Team Compliance Unit Date of previous issue: August 2005 Version: 3 Date of version issue: May 2011 Approved

More information

Patient Demographic / Label. Infection Control Care Plan for a patient with MRSA

Patient Demographic / Label. Infection Control Care Plan for a patient with MRSA Patient Demographic / Label Infection Control Care Plan for a patient with MRSA Statement: This Care Plan should be used with patients who are suspected of or are known to have MRSA. This Care Plan should

More information

Date ratified November Review Date November This Policy supersedes the following document which must now be destroyed:

Date ratified November Review Date November This Policy supersedes the following document which must now be destroyed: Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Cleaning Policy NTW(O)71 James Duncan Deputy Chief Executive / Executive Director of Finance Steve Blackburn Deputy

More information

Inspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust

Inspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust Inspecting Informing Improving Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust December 2008 Outcome of inspection for: Hospital(s) visited: West Hertfordshire Hospitals NHS Trust

More information

STAFF DRESS CODE & UNIFORM POLICY

STAFF DRESS CODE & UNIFORM POLICY STAFF DRESS CODE & UNIFORM POLICY POLICY REFERENCE NUMBER COR015 DATE RATIFIED (this version) July 2016 NEXT REVIEW DATE July 2019 APPROVED BY (state group) Clinical Policy Steering Group ACCOUNTABLE DIRECTOR

More information

Policy Number F9 Effective Date: 17/07/2018 Version: 3 Review Date: 17/07/2019

Policy Number F9 Effective Date: 17/07/2018 Version: 3 Review Date: 17/07/2019 Aim of the Policy This document outlines the policy of Carefound Home Care (the Company ) in relation to infection control. Infection control is the name given to a wide range of policies, procedures and

More information

Pediculosis (Head Lice) Management Protocol

Pediculosis (Head Lice) Management Protocol Pediculosis (Head Lice) Management Protocol General Information Head lice are tiny insects that live only on the scalp of human beings and are the size of a pinhead. They do not have wings so they cannot

More information

MRSA. Information for patients Infection Prevention and Control

MRSA. Information for patients Infection Prevention and Control MRSA Information for patients Infection Prevention and Control What is MRSA? MRSA is a bacterium (germ), which can be found living on the skin of healthy individuals, particularly in the lining of the

More information

Managing medicines in care homes

Managing medicines in care homes Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience

More information

Lincolnshire Partnership NHS Foundation Trust (LPFT) Title of Policy

Lincolnshire Partnership NHS Foundation Trust (LPFT) Title of Policy Lincolnshire Partnership NHS Foundation Trust (LPFT) Title of Policy REF: 7n DOCUMENT VERSION CONTROL Document Type and Title: Correct Use of Personal Protective Environment Authorised Document Folder:

More information

CLOSTRIDIUM DIFFICILE ACTION PLAN

CLOSTRIDIUM DIFFICILE ACTION PLAN CLOSTRIDIUM DIFFICILE ACTION PLAN Action plan to address the rise in cases of Clostridium difficile (C.diff) at Sheffield Teaching Hospitals NHS Foundation Trust ACTION KEY MILESTONES PERSON RESPONSIBLE

More information

Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery

Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery Issue Action Risk to Year-end trajectory for C difficile infections is 29 cases. Week commencing 09.12.13 - Performance

More information

Section G - Aseptic Technique. Version 5

Section G - Aseptic Technique. Version 5 Section G - Aseptic Technique Version 5 Important: This document can only be considered valid when viewed on the Trust s Intranet. If this document has been printed or saved to another location, you must

More information

Policy Objective To provide Health Care Workers (HCWs) with details of the precautions necessary to minimise the risk of MRSA cross-infection.

Policy Objective To provide Health Care Workers (HCWs) with details of the precautions necessary to minimise the risk of MRSA cross-infection. Page 1 of 16 Policy Objective To provide Health Care Workers (HCWs) with details of the precautions necessary to minimise the risk of MRSA cross-infection. This policy applies to all staff employed by

More information

Prevention and control of healthcare-associated infections

Prevention and control of healthcare-associated infections Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process

More information

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Standard Precautions Policy

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Standard Precautions Policy The Newcastle Upon Tyne Hospitals NHS Foundation Trust Version.: 3.2 Effective From: 21 July 2015 Expiry date: 21 July 2018 Date Ratified: 10 July 2015 Ratified By: IPCC 1 Introduction Standard Precautions

More information

Vancomycin-Resistant Enterococcus (VRE)

Vancomycin-Resistant Enterococcus (VRE) Approved by: Vancomycin-Resistant Enterococcus (VRE) Vice President & Chief Medical Officer Corporate Policy & Procedures Manual VI-40 Date Approved July 14, 2016 August 12, 2016 Next Review (3 years from

More information

Cleaning policy. Document author Assured by Review cycle. 1. Introduction Purpose or aim Scope Definitions...

Cleaning policy. Document author Assured by Review cycle. 1. Introduction Purpose or aim Scope Definitions... Cleaning policy Board library reference Document author Assured by Review cycle P005 Head of Estates and Facilities Quality and Standards Committee 3 years This document is version controlled. The master

More information

North East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2)

North East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2) North East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2) No. Objective Actions Lead Date of 1 Leadership throughout Accountability

More information